Royce & Associates Trims Apyx Medical Stake to 5.0%
Ticker: APYX · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 719135
| Field | Detail |
|---|---|
| Company | Apyx Medical Corp (APYX) |
| Form Type | SC 13G/A |
| Filed Date | Jan 23, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, medical-devices
TL;DR
**Royce & Associates cut its Apyx Medical stake to 5.0% as of Dec 31, 2023.**
AI Summary
Royce & Associates, LP, a New York-based investment firm, filed an amended SC 13G/A on January 23, 2024, indicating their ownership in Apyx Medical Corporation (formerly Bovie Medical Corp). As of December 31, 2023, Royce & Associates, LP reported beneficial ownership of 1,939,900 shares of Apyx Medical's Common Stock, representing 5.0% of the company. This filing shows a slight decrease in their reported stake from a previous filing, which could signal a shift in their investment strategy or a minor portfolio adjustment. Investors should note this change as it reflects a significant institutional investor's updated position in Apyx Medical.
Why It Matters
This filing shows a major institutional investor, Royce & Associates, LP, has slightly reduced its stake in Apyx Medical, which could be interpreted as a minor loss of confidence or a portfolio rebalancing. It's important for current and potential shareholders to track such changes as large institutional movements can influence stock perception and liquidity.
Risk Assessment
Risk Level: low — The filing indicates a minor adjustment by an institutional investor, not a complete divestment or a new, aggressive stake, suggesting low immediate risk.
Analyst Insight
Investors should note that a significant institutional investor has slightly reduced its stake. While not a major sell-off, it warrants monitoring future filings from Royce & Associates, LP and Apyx Medical's performance to understand the underlying reasons for this adjustment.
Key Numbers
- 1,939,900 — Shares Beneficially Owned (The number of Apyx Medical Common Stock shares Royce & Associates, LP beneficially owned as of December 31, 2023.)
- 5.0% — Percentage of Class (The percentage of Apyx Medical's Common Stock beneficially owned by Royce & Associates, LP as of December 31, 2023.)
Key Players & Entities
- Royce & Associates, LP (company) — the reporting person and institutional investor
- Apyx Medical Corporation (company) — the subject company whose securities are being reported
- Bovie Medical Corp (company) — Apyx Medical Corporation's former name
- December 31, 2023 (date) — the date of the event requiring the filing
- January 23, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- Royce & Associates, LP will continue to monitor and potentially adjust its stake in Apyx Medical Corporation based on market performance and company fundamentals. (Royce & Associates, LP) — medium confidence, target: Q2 2024
FAQ
Who filed this SC 13G/A amendment regarding Apyx Medical Corporation?
Royce & Associates, LP, an investment firm with a business address at 745 Fifth Avenue, New York, NY, filed this SC 13G/A amendment.
What is the CUSIP number for Apyx Medical Corporation's Common Stock mentioned in the filing?
The CUSIP number for Apyx Medical Corporation's Common Stock is 03837C106, as stated on the cover page of the filing.
What was the 'Date of Event Which Requires Filing of this Statement' for this SC 13G/A?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, according to the filing.
What percentage of Apyx Medical Corporation's Common Stock does Royce & Associates, LP beneficially own as reported in this filing?
Royce & Associates, LP beneficially owns 5.0% of Apyx Medical Corporation's Common Stock, as indicated in the filing.
What was Apyx Medical Corporation's former name, according to the filing?
Apyx Medical Corporation's former name was Bovie Medical Corp, with a name change date of 20150319, as listed under 'FORMER COMPANY' data.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding Apyx Medical Corp (APYX).